16 May 2014
Baffling Chronic Fatigue Syndrome Set for Diagnostic Overhaul
Researchers might soon redefine the mysterious condition, while the latest findings point to the role of brain inflammation
More than one million people in the U.S. suffer from a poorly understood, difficult-to-diagnose condition that can leave them debilitated by unshakable exhaustion, pain, depression and cognitive trouble. Researchers, however, are still unsure what causes
chronic fatigue syndrome (CFS), how to treat it, how best to diagnose it and even what to call it.
A new study is now providing hope for better understanding—and potentially better diagnosing—the disease. It has revealed a striking pattern of brain inflammation in CFS patients. Meanwhile, diagnosis and definition of the disease could soon be getting a major overhaul as a new $1-million
Institute of Medicine (IOM) study gets underway at the request of the
U.S. Department of Health and Human Services (HHS). Is the exhausting search for answers about CFS finally coming to an end?
In your head
Chronic fatigue syndrome was first formally described in the late 1980s. Soon thereafter it was lumped in with another perplexing condition known as myalgic encephalomyelitis (ME), which had been classified as a disease of the nervous system in the 1960s. A precise definition and diagnosis of CFS—sometimes called CFS/ME—has largely eluded doctors and researchers, however. Its subjectively described symptoms seem untestable: everyone is exhausted from time to time; many people suffer from occasional aches and pains; and, sure, we all have foggy days as well as down ones.
A large obstacle is that, unlike cancers or high blood pressure, researchers have no particular biomarkers that would allow them to test for the condition. Doctors rely exclusively on patient reports of the severity and duration of the symptoms—usually requiring the symptoms to be present for at least six consecutive months—along with the presence of extreme post-physical or mental exertion,
fatigue and unrefreshing sleep, to
diagnose the condition. Remissions and relapses confound clinicians further.
A change might be on the distant horizon, however, thanks in part to a new study of the brains of patients living with CFS.
Doctors have long suspected brain inflammation as a potential cause, but no definite traces of it had been detected.
New research, in the June issue of the
Journal of Nuclear Medicine, shows for the first time distinct increases in inflammation in particular regions of CFS patients' brains.
Read more:
http://www.scientificamerican.com/a...fatigue-syndrome-set-for-diagnostic-overhaul/